Atıf İçin Kopyala
ÜNEK İ. T., Akman T., ÖZTOP İ., Unal O. U., Salman T., Yilmaz U.
GASTRIC CANCER, cilt.16, sa.3, ss.428-434, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
16
Sayı:
3
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1007/s10120-012-0206-x
-
Dergi Adı:
GASTRIC CANCER
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.428-434
-
Anahtar Kelimeler:
Advanced gastric cancer, Docetaxel, Cisplatin, Leucovorin, 5-Fluorouracil, PHASE-II TRIAL, PROSPECTIVE RANDOMIZED-TRIAL, PROTRACTED VENOUS-INFUSION, QUALITY-OF-LIFE, PLUS CISPLATIN, FOLINIC ACID, GASTROESOPHAGEAL JUNCTION, 1ST-LINE THERAPY, COMBINATION CHEMOTHERAPY, MITOMYCIN-C
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
The combination of docetaxel, cisplatin, and 5-fluorouracil (DCF) is an effective but highly toxic regimen for the treatment of advanced gastric cancer. To improve tolerability while maintaining the efficacy of the DCF regimen, we developed a modified DCF regimen including an infusional 5-fluorouracil administration according to the de Gramont regimen.